The FDA has granted two Breakthrough Therapy Designations to telisotuzumab adizutecan (Temab-A, also known as ABBV-400), an ...

The designation gives HeartBeam prioritized FDA interaction as it prepares a pivotal study of its 3D ECG technology for ...

VTv Therapeutics said the Food and Drug Administration granted orphan drug designation to HPPD, which is being investigated as a treatment for sickle cell disease.

Vir Biotechnology (VIR) has obtained Fast Track designation for its prostate cancer treatment VIR-5500 from the US Food and Drug Administration, the company said Thursday. The designation was granted ...

Learn more Perspective Therapeutics (CATX) said Thursday that the US Food and Drug Administration, or FDA, granted fast track designation for the development of PSV359, an experimental cancer ...

Medical technology provider HeartBeam, Inc. BEAT received Breakthrough Device Designation from the U.S. Food and Drug ...

Investing.com -- vTv Therapeutics Inc (NASDAQ: VTVT) shares rose 6.4% in premarket trading Thursday after the company announced on Wednesday evening that the FDA granted orphan drug designation to ...

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer ...

The following biotech stocks reached a 52-week high on October 6, 2026, driven by catalysts such as achieving new regulatory ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted orphan drug designation to ligufalimab, a CD47 monoclonal antibody, for treatment of acute ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted orphan drug designation to IKT-001 for treating patients with pulmonary arterial hypertension, ...

HIGH POINT, N.C., Oct. 07, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company advancing ...